Application of Delta Radiomics based on Upper & Middle Lobe Fusion in Diagnosing Mild-to-Moderate Chronic Obstructive Pulmonary Disease

Association of Chest CT-based Radiomics with Pulmonary Function in COPD

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600116411

Enrollment

Unknown

Registered

2026-01-09

Start date

2024-08-21

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

COPD group:None

Healthy control group:None

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meets the GOLD 2024 clinical diagnostic criteria and is clinically diagnosed as a patient with mild, moderate, severe, or extremely severe COPD; 2. Typical clinical symptoms without any other complications; 3. Complete clinical data (age, gender, height, weight, smoking history) and imaging data; 4. Unrestricted ventilatory dysfunction.

Exclusion criteria

Exclusion criteria: 1. Chest malformation or lung surgery, the latter; 2. Individuals with inflammation or infection in the lungs; 3. Combine patients with other complications that affect lung function, such as asthma, bronchiectasis, tuberculosis, etc; 4. Individuals with a history of breast surgery; 5. Those who are confused and uncooperative; 6. Patients with incomplete clinical and CT imaging data.

Design outcomes

Primary

Measure	Time frame
Lung function test data;Quantitative ct indicators;area under receiver operating characteristic curve, ROC;Decision curve analysis, DCA;	—

Countries

China

Contacts

Public ContactLihua Zhang

Department of Radiology, Heping Hospital Affiliated to Changzhi Medical College

hpfskzlh@126.com+86 133 8355 3629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026